广州誉衡生物科技有限公司

Country

Ownership: -

Established: 2016-03-23

Employees: -

Market Cap: -

Website: https://www.gloriabio.com

Clinical Trials

0

Active:0

Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Zimberelimab Injection

Product Name: 誉妥

Approval Number: 国药准字S20210034

Approval Date: Aug 25, 2021

NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.